Literature DB >> 11989825

VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion.

Mads Nordahl Svendsen1, Kim Werther, Hans Jørgen Nielsen, Paul E G Kristjansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11989825     DOI： 10.1080/003655202317315971

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  9 in total

Review 1.  Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement.

Authors:  Elad Neeman; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-04-04       Impact factor: 7.217

2.  Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma.

Authors:  Yong Li; You-Bing Zheng; Wei Zhao; Bing Liu; Bao-Shan Hu; Xu He; Jian-Wen Huang; Li-Gong Lu
Journal:  Med Oncol       Date:  2013-09-19       Impact factor: 3.064

3.  TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.

Authors:  Sven Mahner; Linn Woelber; Christine Eulenburg; Joerg Schwarz; Walter Carney; Fritz Jaenicke; Karin Milde-Langosch; Volkmar Mueller
Journal:  BMC Cancer       Date:  2010-04-13       Impact factor: 4.430

4.  MiR-9 regulates the post-transcriptional level of VEGF165a by targeting SRPK-1 in ARPE-19 cells.

Authors:  Changshin Yoon; Daejin Kim; Seonghan Kim; Ga Bin Park; Dae Young Hur; Jae Wook Yang; Sae Gwang Park; Yeong Seok Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-10       Impact factor: 3.117

5.  Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.

Authors:  An Coosemans; Judit Decoene; Thaïs Baert; Annouschka Laenen; Ahmad Kasran; Tina Verschuere; Sven Seys; Ignace Vergote
Journal:  Oncoimmunology       Date:  2015-12-21       Impact factor: 8.110

6.  Clinical significance of coagulation factors in operable colorectal cancer.

Authors:  Suee Lee; Seok Jae Huh; Sung Yong Oh; Myeong Seok Koh; Sung-Hyun Kim; Ji Hyun Lee; Jin Young Han; Hong Jo Choi; Su Jin Kim; Hyo-Jin Kim
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

Review 7.  Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management.

Authors:  Renata Zajączkowska; Wojciech Leppert; Joanna Mika; Magdalena Kocot-Kępska; Jarosław Woroń; Anna Wrzosek; Jerzy Wordliczek
Journal:  Pain Res Manag       Date:  2018-09-19       Impact factor: 3.037

8.  Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation.

Authors:  Shi-Han Feng; Bin Zhao; Xue Zhan; Retsepile Motanyane; Shu-Mei Wang; Ao Li
Journal:  Drug Des Devel Ther       Date:  2021-02-24       Impact factor: 4.162

Review 9.  Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer.

Authors:  Alejandra Wu Chuang; Oliver Kepp; Guido Kroemer; Lucillia Bezu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.